jie lu
jie lu
Verified email at ucla.edu
Cited by
Cited by
Guidelines for the use and interpretation of assays for monitoring autophagy
DJ Klionsky, K Abdelmohsen, A Abe, MJ Abedin, H Abeliovich, ...
autophagy 12 (1), 1-222, 2016
Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery
M Liong, J Lu, M Kovochich, T Xia, SG Ruehm, AE Nel, F Tamanoi, JI Zink
ACS nano 2 (5), 889-896, 2008
Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs
J Lu, M Liong, JI Zink, F Tamanoi
small 3 (8), 1341-1346, 2007
Biocompatibility, biodistribution, and drug‐delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals
J Lu, M Liong, Z Li, JI Zink, F Tamanoi
Small 6 (16), 1794-1805, 2010
Light-activated nanoimpeller-controlled drug release in cancer cells
J Lu, E Choi, F Tamanoi, JI Zink
Small (Weinheim an der Bergstrasse, Germany) 4 (4), 421, 2008
Identification of arctigenin as an antitumor agent having the ability to eliminate the tolerance of cancer cells to nutrient starvation
S Awale, J Lu, SK Kalauni, Y Kurashima, Y Tezuka, S Kadota, H Esumi
Cancer research 66 (3), 1751-1757, 2006
Synthesis of biomolecule‐modified mesoporous silica nanoparticles for targeted hydrophobic drug delivery to cancer cells
DP Ferris, J Lu, C Gothard, R Yanes, CR Thomas, JC Olsen, JF Stoddart, ...
Small 7 (13), 1816-1826, 2011
Mesoporous silica nanoparticles facilitate delivery of siRNA to shutdown signaling pathways in mammalian cells
C Hom, J Lu, M Liong, H Luo, Z Li, JI Zink, F Tamanoi
Small (Weinheim an der Bergstrasse, Germany) 6 (11), 1185, 2010
In vivo tumor suppression efficacy of mesoporous silica nanoparticles-based drug-delivery system: enhanced efficacy by folate modification
J Lu, Z Li, JI Zink, F Tamanoi
Nanomedicine: Nanotechnology, Biology and Medicine 8 (2), 212-220, 2012
Mesoporous silica nanoparticles for cancer therapy: energy-dependent cellular uptake and delivery of paclitaxel to cancer cells
J Lu, M Liong, S Sherman, T Xia, M Kovochich, AE Nel, JI Zink, F Tamanoi
Nanobiotechnology 3 (2), 89-95, 2007
Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy
H Mekaru, J Lu, F Tamanoi
Advanced drug delivery reviews 95, 40-49, 2015
Identification of a novel protein kinase mediating Akt survival signaling to the ATM protein
A Suzuki, G Kusakai, A Kishimoto, J Lu, T Ogura, MF Lavin, H Esumi
Journal of Biological Chemistry 278 (1), 48-53, 2003
ARK5 is a tumor invasion-associated factor downstream of Akt signaling
A Suzuki, J Lu, G Kusakai, A Kishimoto, T Ogura, H Esumi
Molecular and cellular biology 24 (8), 3526-3535, 2004
Antitumor activity of pyrvinium pamoate, 6‐(dimethylamino)‐2‐[2‐(2,5‐dimethyl‐1‐phenyl‐1H‐pyrrol‐3‐yl)ethenyl]‐1‐methyl‐quinolinium pamoate salt, showing …
H Esumi, J Lu, Y Kurashima, T Hanaoka
Cancer science 95 (8), 685-690, 2004
Protein-gold clusters-capped mesoporous silica nanoparticles for high drug loading, autonomous gemcitabine/doxorubicin co-delivery, and in-vivo tumor imaging
JG Croissant, D Zhang, S Alsaiari, J Lu, L Deng, F Tamanoi, AM AlMalik, ...
Journal of Controlled Release 229, 183-191, 2016
ARK5 suppresses the cell death induced by nutrient starvation and death receptors via inhibition of caspase 8 activation, but not by chemotherapeutic agents or UV irradiation
A Suzuki, G Kusakai, A Kishimoto, J Lu, T Ogura, H Esumi
Oncogene 22 (40), 6177-6182, 2003
Involvement of lysosomal exocytosis in the excretion of mesoporous silica nanoparticles and enhancement of the drug delivery effect by exocytosis inhibition
RE Yanes, D Tarn, AA Hwang, DP Ferris, SP Sherman, CR Thomas, J Lu, ...
Small 9 (5), 697-704, 2013
Kigamicin D, a novel anticancer agent based on a new anti‐austerity strategy targeting cancer cells' tolerance to nutrient starvation
J Lu, S Kunimoto, Y Yamazaki, M Kaminishi, H Esumi
Cancer science 95 (6), 547-552, 2004
Two‐Photon‐Triggered Drug Delivery via Fluorescent Nanovalves
J Croissant, A Chaix, O Mongin, M Wang, S Clément, L Raehm, ...
Small 10 (9), 1752-1755, 2014
Chemopreventive Effect of Peroxisome Proliferator–Activated Receptor γ on Gastric Carcinogenesis in Mice
J Lu, K Imamura, S Nomura, K Mafune, A Nakajima, T Kadowaki, ...
Cancer research 65 (11), 4769-4774, 2005
The system can't perform the operation now. Try again later.
Articles 1–20